Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Equivalency Study of Two Formulations of Budesonide Inhalation Aerosol

NCT06924190 is registered in ClinicalTrials.gov with Lunan Better Pharmaceutical Co., LTD. as lead sponsor.

NCT NCT06924190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06924190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Equivalency Study of Two Formulations of Budesonide Inhalation Aerosol
Lead sponsor
Lunan Better Pharmaceutical Co., LTD.
Phase
Not applicable
Overall status
Completed
Start date
December 30, 2024
Completion date
January 20, 2025
Enrollment
32 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bioequivalence study in healthy subjects